β-Amyloid burden in healthy aging: regional distribution and cognitive consequences
- PMID: 22302550
- PMCID: PMC3280058
- DOI: 10.1212/WNL.0b013e318245d295
β-Amyloid burden in healthy aging: regional distribution and cognitive consequences
Abstract
Objective: Several lines of evidence suggest that pathologic changes underlying Alzheimer disease (AD) begin years prior to the clinical expression of the disease, underscoring the need for studies of cognitively healthy adults to capture these early changes. The overall goal of the current study was to map the cortical distribution of β-amyloid (Aβ) in a healthy adult lifespan sample (aged 30-89), and to assess the relationship between elevated amyloid and cognitive performance across multiple domains.
Methods: A total of 137 well-screened and cognitively normal adults underwent Aβ PET imaging with radiotracer (18)F-florbetapir. Aβ load was estimated from 8 cortical regions. Participants were genotyped for APOE and tested for processing speed, working memory, fluid reasoning, episodic memory, and verbal ability.
Results: Aβ deposition is distributed differentially across the cortex and progresses at varying rates with age across cortical brain regions. A subset of cognitively normal adults aged 60 and over show markedly elevated deposition, and also had a higher rate of APOE ε4 (38%) than nonelevated adults (19%). Aβ burden was linked to poorer cognitive performance on measures of processing speed, working memory, and reasoning.
Conclusions: Even in a highly selected lifespan sample of adults, Aβ deposition is apparent in some adults and is influenced by APOE status. Greater amyloid burden was related to deleterious effects on cognition, suggesting that subtle cognitive changes accrue as amyloid progresses.
Figures



Similar articles
-
Amyloid-β and cognition in aging and Alzheimer's disease: molecular and neurophysiological mechanisms.J Alzheimers Dis. 2013;33 Suppl 1:S79-86. doi: 10.3233/JAD-2012-129003. J Alzheimers Dis. 2013. PMID: 22531423 Review.
-
Aβ-amyloid deposition in patients with Parkinson disease at risk for development of dementia.Neurology. 2012 Sep 11;79(11):1161-7. doi: 10.1212/WNL.0b013e3182698d4a. Epub 2012 Aug 29. Neurology. 2012. PMID: 22933741 Free PMC article.
-
Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population.PLoS One. 2015 Jul 29;10(7):e0123743. doi: 10.1371/journal.pone.0123743. eCollection 2015. PLoS One. 2015. PMID: 26221954 Free PMC article. Clinical Trial.
-
Cognitive consequences of high Aβ amyloid in mild cognitive impairment and healthy older adults: implications for early detection of Alzheimer's disease.Neuropsychology. 2013 May;27(3):322-332. doi: 10.1037/a0032321. Neuropsychology. 2013. PMID: 23688214
-
Long night's journey into the day: amyloid-β imaging in Alzheimer's disease.J Alzheimers Dis. 2013;33 Suppl 1:S349-59. doi: 10.3233/JAD-2012-129034. J Alzheimers Dis. 2013. PMID: 22710919 Review.
Cited by
-
The aging brain and cognition: contribution of vascular injury and aβ to mild cognitive dysfunction.JAMA Neurol. 2013 Apr;70(4):488-95. doi: 10.1001/2013.jamaneurol.405. JAMA Neurol. 2013. PMID: 23400560 Free PMC article.
-
Past and future episodic detail retrieval is reduced among clinically normal older adults at higher genetic risk for late-onset Alzheimer's disease.Neuropsychology. 2023 Feb;37(2):194-203. doi: 10.1037/neu0000866. Epub 2022 Nov 28. Neuropsychology. 2023. PMID: 36442007 Free PMC article.
-
Theories of Memory and Aging: A Look at the Past and a Glimpse of the Future.J Gerontol B Psychol Sci Soc Sci. 2017 Jan;72(1):82-90. doi: 10.1093/geronb/gbw066. Epub 2016 Jun 2. J Gerontol B Psychol Sci Soc Sci. 2017. PMID: 27257229 Free PMC article. Review.
-
Longitudinal Positron Emission Tomography in Preventive Alzheimer's Disease Drug Trials, Critical Barriers from Imaging Science Perspective.Brain Pathol. 2016 Sep;26(5):664-71. doi: 10.1111/bpa.12399. Brain Pathol. 2016. PMID: 27327527 Free PMC article.
-
Multi-omics signature of brain amyloid deposition in asymptomatic individuals at-risk for Alzheimer's disease: The INSIGHT-preAD study.EBioMedicine. 2019 Sep;47:518-528. doi: 10.1016/j.ebiom.2019.08.051. Epub 2019 Sep 3. EBioMedicine. 2019. PMID: 31492558 Free PMC article.
References
-
- Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 2002;297:353–356 - PubMed
-
- Price JL, Morris JC. Tangles and plaques in nondemented aging and “preclinical” Alzheimer's disease Ann Neurol 1999;45:358–368 - PubMed
-
- Bennett D, Schneider J, Arvanitakis Z, et al. Neuropathology of older persons without cognitive impairment from two community-based studies. Neurology 2006;66:1837. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous